<DOC>
	<DOCNO>NCT01314391</DOCNO>
	<brief_summary>RATIONALE : Studying sample blood tissue patient cancer laboratory may help doctor learn change occur DNA identify biomarkers related cancer . PURPOSE : This research study study biomarkers blood tumor tissue sample patient Wilms tumor .</brief_summary>
	<brief_title>Biomarkers Blood Tumor Tissue Samples From Patients With Wilms Tumor</brief_title>
	<detailed_description>OBJECTIVES : - To determine whether Wilms Tumor ( WT ) patient without WT1-associated congenital anomaly syndrome , end-stage renal disease ( ESRD ) unrelated progressive bilateral tumor , carry germline WT1 mutation . - To determine whether non-syndromic WT1 germline mutation carrier substantially high incidence ESRD WT patient harbor WT1 mutation . OUTLINE : Archived blood tumor tissue specimen ( DNA isolate sample ) analyze WT1 mutation gene sequence PCR .</detailed_description>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Kidney Neoplasms</mesh_term>
	<mesh_term>Wilms Tumor</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis Wilms Tumor ( WT ) Patients participate NWTS5 protocol Nonsyndromic patient develop endstage renal disease ( ESRD ) 510 year reason progressive bilateral WT Matched control patient develop ESRD time ( since WT onset ) ESRD diagnosis Blood tumor tissue sample available PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>stage I Wilms tumor</keyword>
	<keyword>stage II Wilms tumor</keyword>
	<keyword>stage III Wilms tumor</keyword>
	<keyword>stage IV Wilms tumor</keyword>
	<keyword>stage V Wilms tumor</keyword>
	<keyword>renal failure</keyword>
</DOC>